Journal article
Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study
Abstract
BACKGROUND: Despite the use of aspirin, there is still a risk of ischaemic events after percutaneous coronary intervention (PCI). We aimed to find out whether, in addition to aspirin, pretreatment with clopidogrel followed by long-term therapy after PCI is superior to a strategy of no pretreatment and short-term therapy for only 4 weeks after PCI.
METHODS: 2658 patients with non-ST-elevation acute coronary syndrome undergoing PCI in the CURE …
Authors
Mehta SR; Yusuf S; Peters RJ; Bertrand ME; Lewis BS; Natarajan MK; Malmberg K; Rupprecht H-J; Zhao F; Chrolavicius S
Journal
The Lancet, Vol. 358, No. 9281, pp. 527–533
Publisher
Elsevier
Publication Date
8 2001
DOI
10.1016/s0140-6736(01)05701-4
ISSN
0140-6736
Associated Experts
Fields of Research (FoR)
Medical Subject Headings (MeSH)
AgedAngioplasty, Balloon, CoronaryAspirinClopidogrelCoronary DiseaseDouble-Blind MethodFemaleHumansLogistic ModelsMaleMiddle AgedMyocardial InfarctionMyocardial RevascularizationPlatelet Aggregation InhibitorsPreoperative CareProportional Hazards ModelsProspective StudiesRiskSurvival AnalysisTiclopidineTreatment Outcome